Titlebook: Drugs for Heart Disease; John Hamer Book 1987 Springer Science+Business Media Dordrecht 1987 cardiovascular.drugs.heart.heart disease.hear

foresight

書目名稱Drugs for Heart Disease影響因子(影響力)




書目名稱Drugs for Heart Disease影響因子(影響力)學(xué)科排名




書目名稱Drugs for Heart Disease網(wǎng)絡(luò)公開度




書目名稱Drugs for Heart Disease網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Drugs for Heart Disease被引頻次




書目名稱Drugs for Heart Disease被引頻次學(xué)科排名




書目名稱Drugs for Heart Disease年度引用




書目名稱Drugs for Heart Disease年度引用學(xué)科排名




書目名稱Drugs for Heart Disease讀者反饋




書目名稱Drugs for Heart Disease讀者反饋學(xué)科排名

Infelicity

有效

制定

Prostaglandins and cardiovascular medicine, synthesize them on a large scale, and although for a time much of the world’s supply was derived from coral polyps of the . genus, it was not until the early 1970s that fully synthetic methods were availiable for the manufacture of prostaglandins [1].

欄桿

arrhythmic

arrhythmic

between the two disciplines. In this second edition I have not tried to be encyclopaedic, but have asked the contributors to give a brief account of current practice, so that it represents the present state of cardiac thera- peutics. Although some contributors are from Bart‘s, I have tried to spread

離開就切除

ed to be held in high esteem well into the nineteenth century. In a text entitled: ., Stokes states: ‘the exhibition of mercury will, as if by enchantment, remove the anasarca’. [1]. However, such treatments bore the harsh penalty of substantial toxicity [2].

Exposure

ated with diastolic BP above 90 mmHg [2, 3]. Since the major goal in treating patients with hypertension is to prevent the morbidity and mortality attributable to high BP, this means the reduction of elevated BP to the extent that excess cardiovascular risk is minimized.

ethnology